Recently, combination of CEA-CAR-NK-92 cells with the HDAC inhibitor sodium butyrate (NaB) led to CEA upregulation in CRC cells, increasing CEA-CAR-NK-92 cell-mediated killing in an in vivo model, leading to reduced tumor volumes (162). Here, CEACAM5 is linked to neoplasm.